Most individuals with chronic kidney disease (CKD) are unaware of their disease, according to a KDIGO controversies conference on CKD prevention.

SGLT2 inhibitor use may help stabilize eGFR levels for patients with autosomal dominant polycystic kidney disease and type 2 diabetes, according to study data.“Given its unique pathophysiology, ...

An elderly man with immunoglobulin G4-related disease (IgG4-RD) with kidney involvement and monoclonal gammopathy was successfully treated with corticosteroid therapy. This case report was published ...

Exposure to trihalomethanes—especially brominated trihalomethanes—in residential community water supplies (CWS) is associated ...

Drinking water chemical may raise kidney disease risk…microplastics detected in human reproductive fluids…air pollution ...

2017 is an important year for the international nephrology community. March 9 was World Kidney Day, the theme this year being ‘Kidney disease and obesity: healthy lifestyles for healthy kidneys’, ...

Idiopathic nephrotic syndrome (INS) is a serious kidney disease in children with no clear cause. In a recent study, researchers have identified a novel autoantibody targeting vinculin—a protein ...

It’s actually a chronic disease.” Saving people on the brink of dying from a drug overdose may be the most dramatic way that Central Neighborhood Health Foundation is combating the opioid epidemic, ...

Introduction The number of persons with chronic kidney disease (CKD) living in low- and middle-income countries (LMIC) is increasing rapidly; yet systems built to care for them have received little ...

Otsuka Pharmaceutical has shared more detailed data behind its kidney disease drug’s phase 3 win, showing the monoclonal antibody halved patients’ urine protein-to-creatinine ratio (UPCR) levels.

The projected yearly incidence of hospitalized patients with chronic liver disease also increased during this time — from 2,288,242 in 2018 to 2,754,542 in 2023.